US FDA approves Biogen-Sage Therapeutics pill for postpartum depression By Reuters
© Reuters (Reuters) -The U.S. Food and Drug Administration (FDA) on Friday approved Biogen (NASDAQ:) and Sage Therapeutics' oral pill ...
© Reuters (Reuters) -The U.S. Food and Drug Administration (FDA) on Friday approved Biogen (NASDAQ:) and Sage Therapeutics' oral pill ...
Copyright © 2022 - Index Investing News.
Index Investing News is not responsible for the content of external sites.